Lilly's Foundayo pill cut sleep apnea severity in yearlong trials, with an FDA filing next
The daily GLP-1 pill reduced breathing interruptions with or without CPAP, though most patients still had more than mild sleep apnea after a year.
Health
Health news on medical research, new treatments and drug approvals, disease outbreaks, nutrition and mental health.
